Initial macular thickness and response to treatment in diabetic macular edema

Retina

Volumn 31, Issue 8, 2011, Pages 1564-1573

  Soheilian, Masoud ^a,b   Ramezani, Alireza ^a,b   Yaseri, Mehdi ^a   Mirdehghan, Seyed Ali ^a,b   Obudi, Arash ^a,b   Bijanzadeh, Bijan ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Negah Eye Hospital   (Iran)

Author keywords

bevacizumab; clinically significant diabetic macular edema; diabetic macular edema; diabetic retinopathy; macular laser photocoagulation; macular thickness; optical coherence tomography; triamcinolone acetonide

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BODY WEIGHTS AND MEASURES; DIABETIC RETINOPATHY; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 80052439791     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820bde7d     Document Type: Article

References (16)

1. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9. (Pubitemid 14184710)
2. Hardy R, Crawford J. Retina. In: Vaughn D, Asbury T, Riordan-Eva P, eds. General Ophthalmology. 15th ed. Stamford: Appleton & Lange; 1999:178-199.
3. Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-1371, 1371.e1.
4. Danis RP, Glassman AR, Aiello LP, et al. Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006;124:1701-1707. (Pubitemid 44913193)
5. Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114:525-536.
6. Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004;111:712-715. (Pubitemid 38429668)
7. Hussain A, Hussain N, Nutheti R. Comparison of mean macular thickness using optical coherence tomography and visual acuity in diabetic retinopathy. Clin Experiment Ophthalmol 2005;33:240-245. (Pubitemid 41602391)
8. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741-756.
9. Rand LI, Prud'homme GJ, Ederer F, Canner PL. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10. Invest Ophthalmol Vis Sci 1985;26:983-991. (Pubitemid 15071719)
10. Ip MS, Bressler SB, Antoszyk AN, et al. A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: Baseline features. Retina 2008;28:919-930.
11. Estabrook EJ, Madhusudhana KC, Hannan SR, Newsom RS. Can optical coherence tomography predict the outcome of laser photocoagulation for diabetic macular edema? Ophthalmic Surg Lasers Imaging 2007;38:478-483.
12. Shahidi M, Ogura Y, Blair NP, Zeimer R. Retinal thickness change after focal laser treatment of diabetic macular oedema. Br J Ophthalmol 1994;78:827-830. (Pubitemid 24345946)
13. Soheilian M, Ramezani A, Bijanzadeh B, et al. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 2007;27:1187-1195. (Pubitemid 350211523)
14. Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009;116:1142-1150.
15. Krzystolik MG, Strauber SF, Aiello LP, et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114:1520-1525.
16. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, et al. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 2002;43: 1588-1594. (Pubitemid 34462662)